Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized amikacin adjunctive therapy for Gram-negative ventilator-associated pneumonia
ChiCTR-ONRC-12002697Phase 4Completed
- Sponsor
- Shanghai Fifth People's Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amikacin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Shanghai Fifth People's Hospital. Primary endpoints: mortality and weaning rate. Started Oct 2009; status: completed.
02
Drugs
amikacin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on ChiCTR-ONRC-12002697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002697.